We'll use AI to spot more prostate cancer, says Science Secretary
Peter Kyle told The Telegraph that the Government is investing £168m on initiatives to use public data better and one major goal is to improve cancer screening on the NHS.
A world-leading initiative led by Cancer Research UK has been given £10m in funding to improve cancer screening methods by identifying the most at-risk people and offering them personalised tests.
The funding will 'develop AI-powered tools that can predict cancer risk', Mr Kyle said, and could save thousands of lives a year.
The Telegraph has launched a campaign calling for a targeted national screening programme for prostate cancer, which focusses on men who are at the greatest risk.
This includes men over 50, black men, whose risk is twice that of white men, and those with a family history of prostate cancer.
Steve McQueen, Bob Willis and Chris Hoy are some of the high-profile British men to be recently diagnosed with the condition. Around 55,000 men are diagnosed with prostate cancer annually in England and around 33 men a day die from the condition.
Writing for The Telegraph alongside Stian Westlake, the executive chairman of the Economic and Social Research Council, Mr Kyle said: 'This funding will support work on a project linking health records to demographics, family history and behaviour to identify those at higher risk of this devastating illness, so that it can be treated early – potentially saving thousands of lives every year.'
The plan is to create flexible national screening programmes which can pick up more cases in individuals who may otherwise be missed and diagnosed only when the cancer was incurable.
Officials are hoping to replicate the success of BRCA1 genetic screening. Around one in 400 people has faulty BRCA genes, which give women a 60 per cent chance of developing breast cancer.
This received widespread attention and became known as the 'Angelina Jolie gene' after the Hollywood actress underwent a double mastectomy after finding out she was a carrier in 2013.
The NHS now offers genetic tests to high-risk groups, such as Jewish women, to catch as many cases early as possible.
Mr Kyle said: 'Just as BRCA gene screening, heroically brought to the fore by campaigners including Angelina Jolie, revolutionised how we understand and manage the risk of hereditary breast cancer, this next generation of data-driven screening could do the same for more cancers, including prostate cancer.'
Scientists running the scheme hope it can enable the NHS to offer more frequent cancer screening sessions or screening at a younger age to those at higher risk, while those at lower risk could be spared unnecessary tests.
People identified as higher risk could also be sent for cancer testing faster when they go to their GP with possible symptoms.
The wider Administrative Data Partnership will last until 2031 and try to repurpose data that already exists to make improvements to the judicial service, education, health and other public sectors.
Combining, standardising and interpreting different datasets simultaneously is a daunting challenge for scientists owing to decades of independent data collection and little crossover.
However, the Government believes that vast data reserves, combined with the power of AI computing, could transform healthcare.
The cancer screening project will build new models over the next five years to merge relevant data as well as creating algorithms which will process it and ensure the results are accurate and reliable.
Antonis Antoniou, the programme director and professor of cancer risk prediction at the University of Cambridge, said: 'The UK's strengths in population-scale data resources, combined with advanced analytical tools like AI, offer tremendous opportunities to link disparate datasets and uncover clues that could lead to earlier detection, diagnosis, and prevention of more cancers.'
Dr David Crosby, the head of prevention and early detection research at Cancer Research UK, told The Telegraph: 'The single most important thing we can do to beat cancer is to find it earlier, when treatment is more likely to be successful.
'With half a million cancer cases per year expected in the UK by 2040, we need a major shift towards more accurate diagnosis and detection of early cancer.
'The Cancer Data Driven Detection programme will link health data sources together and build the powerful new tools doctors need to identify those at highest risk of cancer and prioritise resources towards them.
'Moving towards a preventative approach to healthcare will not be easy and will take time. Cancer Research UK's investment in the programme is an investment in the future of cancer care.'
Data is the key to changing lives for the better
By Peter Kyle and Stian Westlake
For much of our everyday lives, data is king – from digital maps getting us from A to B, to health apps keeping our fitness and sleep in check, to even streaming platforms suggesting the next drama we might want to get stuck into.
For this government, making good use of data is the difference between successful policies that are rooted in evidence, and those that rely on hope, luck or intuition, which no minister, legislator or council leader wants to rely on. Ultimately data is the bedrock of decision-making, ensuring policies, programmes and funding are doing what they are intended to do – changing lives for the better.
Linking data from across government to the national pupil database for example can help to really dig into the source of inequalities that trap too many Brits from childhood through to the labour market – helping us to take targeted action in boosting social mobility and shattering glass ceilings.
Or by better applying it in the justice system, we can understand patterns of reoffending, stopping career criminals from inflicting more misery on the law-abiding majority. And it can forecast the impact that this government extending the national living wage has on younger workers, so that millions more who put the hours in take home the pay they deserve.
What unites all of these examples is that they were all made possible by UKRI's administrative data research UK partnership.
It works to connect, and make sense of, the huge wealth of data that is generated by government services, bringing it to our world class researchers securely and with the public's privacy at heart since 2018. In short it has been demonstrating the role data can play in improving lives in as many ways as we can imagine and more.
But we know we can go further and too many social and economic researchers – many of the very best of whom are right here in the UK – simply can't access the data they need.
It is fragmented and siloed, held in different datasets by different public organisations. That means too many rely instead on insights from abroad, which while offering much, simply can't tell the full story of life in Britain in 2025.
Accessing the raw resource of all that data and translating it into a form that researchers can use is no easy task, and while we need to grow our data science expertise, we also need to build relationships and make the case to other organisations that secure data sharing has the power to change lives.
That is why UKRI is investing a further £168m to continue ADR UK's programme of work through to 2031.
This includes continuing our partnership with Cancer Research UK to develop AI-powered tools that can predict cancer risk based on health records, family history and behaviour.
Just as BRCA gene screening, heroically brought to the fore by campaigners including Angelina Jolie, revolutionised how we understand and manage the risk of hereditary breast cancer, this next generation of data-driven screening could do the same for more cancers, including prostate cancer.
This funding will support work with organisations and charities like Cancer Research UK for example, on a project linking health records to demographics, family history, and behaviour to identify those at higher risk of this devastating illness, so that it can be treated early – potentially saving thousands of lives every year.
The ADR will also offer learnings for and help us shape our new national data library, a central government resource designed to bring together existing research programmes and make it easier for policymakers and public bodies to access and use data securely to improve public services.
As the incredible opportunities and challenges of technology like AI advance at unprecedented speeds and as we grapple with the fate of our planet as our climate changes, using data to drive policy for the generations to come has never been more important.
This government is driven by a plan for change that will transform the lives of the British people, from growing our economy so that our payslips go further, to unlocking opportunity for everyone regardless of background, and building an NHS that is fit for the future and makes the most of the opportunities in new technology.
Data can play a huge part in getting that right and targeting government support where it is needed most.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
3 minutes ago
- The Independent
Pharmacy warning of unsustainable demand for weight loss medication
The National Pharmacy Association (NPA) has issued a warning that the burgeoning demand for weight loss injections may be unsustainable, citing a significant mismatch between public interest and clinical suitability for the treatments. The NPA, which represents over 6,000 independent community pharmacies, highlighted this concern. A poll commissioned by the association revealed that 21 per cent of respondents had attempted to access weight loss treatments in the past year, either online or directly from a pharmacy. This figure surged to 35 per cent among 16 to 34-year-olds, contrasting sharply with just seven per cent of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'
Telegraph
3 hours ago
- Telegraph
Grandmother died of sepsis after being misdiagnosed with stomach complaint
A grandmother died of sepsis after doctors failed to recognise signs of a urinary tract obstruction, a coroner has found. Suzanne Edwards, 71, of Leighton Buzzard, Bedfordshire, visited her GP on Nov 29 2024 with abdominal pain and vomiting but despite urgent blood and urine tests she was not sent to hospital. Later that day her symptoms worsened and she went to A&E at Milton Keynes University Hospital, Bucks. Her test results were indicative of systemic inflammation and dehydration but she was diagnosed with gastroenteritis and discharged. Her condition deteriorated further and the following day her family called NHS 111. She was directed to an urgent care centre and transferred to Bedford Hospital where clinicians identified a 7mm stone in her urinary tract and sepsis. She underwent emergency surgery but died later on the evening of Dec 1 from septic shock. 'Heart of our family' Stacey Edwards, her daughter, said: 'My mum was the heart of our family – full of warmth, compassion and humour. 'It's devastating to know that her death may have been avoided if the signs of sepsis had been recognised sooner.' Her family described her as 'an unbelievably kind and caring woman with a wicked sense of humour and fun'. She leaves behind husband Terence, two children and two granddaughters. Stacey said: 'When she visited her GP she was so unwell she used a wheelchair. 'After she was taken to A&E we were told it was likely gastroenteritis. She was given IV fluids and pain relief but she was still in pain and struggling. 'There was very little communication from doctors and when she was discharged we were simply told to come back if symptoms returned. 'At home, things got worse. But because she'd been examined by medical professionals we thought she just needed time to recover. 'The call we received later that evening asking us to come in urgently is something we'll never forget. 'Neither is watching her suffer in those final days.' Jewellery went missing Soon after her death Mrs Edwards' family realised her jewellery worth thousands of pounds – three necklaces and four bracelets – were missing. Stacey said: 'Mum never took off her jewellery. 'It is heartbreaking to think someone may have taken advantage of such a tragic situation.' Bedfordshire Hospitals NHS Foundation Trust launched a full investigation and search at the time but the items were never found. Tom Osborne, the senior coroner for Milton Keynes, recorded a narrative verdict saying there was a failure to recognise the signs of a urinary tract obstruction, leading to missed opportunities to treat Mrs Edwards before sepsis developed.
The Guardian
5 hours ago
- The Guardian
Parents, beware the devastating consequences of measles
After reading the letters about vaccine misinformation and hesitancy (Measles surge shows why vaccinations are crucial, 20 July), I felt I must write to tell you of one unrecognised cause of the drop in vaccine uptake: when I worked as a community school nursing sister in the 1980s, with 11 state schools and a number of private schools that took up the vaccine service, we had 98% uptake of vaccines in the school setting. This was due to the system of sending letters home to parents requesting their consent and following up by phone, if necessary, by the school office staff. The children came in class batches. Then the local health authority decided that this service should be discontinued and parents were invited to take their child to the local GP surgery for their vaccinations. The uptake plummeted to less than 40% of eligible children due to children not taking the letters home, or parents forgetting or losing the letter – or being unable to take time off to take their child to the surgery. When I asked the GPs at the local health centre what the uptake for the cohort of eligible children was, they looked at their records and were surprised, but reluctant to do anything about it. Health visitors were responsible for, and very successful in, advising new mothers when vaccines were due, where to get them and encouraging uptake. It should be compulsory for all vaccines for preschool children (which includes measles) to be done before a child is admitted to school, as in many other countries. As a midwife, I saw a baby born to a mother who had contact with rubella in early pregnancy. The little girl was born with a body rash, had bilateral cataracts and was totally deaf. She was was very ill. Schools for deaf children may return again for these children if vaccination is not taken up for whatever reason. How StephensLiphook, Hampshire I contracted measles just before the NHS was established. With it came serious ear infections, burst eardrums, etc. There were no vaccines, just ear drops. Over the years the infections and operations continued and now, aged 82, I have no hearing with complications. I beg people to think seriously about vaccination. The consequences of measles can sometimes be devastating. Jean JacksonSeer Green, Buckinghamshire I caught measles aged six in 1953, at a time when parents hoped their children would get it (and chicken pox and mumps) so as to gain immunity. My dad, aged 54, had not had measles as a boy, caught it from me and nearly died. The risk of not vaccinating children is not just to WallLondon
